Pharmafile Logo
Pharmafocus logo
Advanced Search
Eylea picture

Lucentis rival gains US approval

November 22, 2011
Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche

A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …

News

Gilead aims for hep C lead with Pharmasset acquisition

November 22, 2011
Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C

Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …

News
Willetts opens the new Celgene headquarters

Celgene opens new headquarters in UK

November 21, 2011
Research and Development, Sales and Marketing Celgene

Celgene has opened new UK headquarters in London as its haematology-based business expands. The firm says it has decided to …

News

Update on the planned consolidation of UK medicines legislation

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Earlier this year we reported on progress in the consolidation of the UK medicines legislation and that the Medicines and …

News
Press release

EMA accepts submission of Pfizer’s new arthritis drug

November 21, 2011
Research and Development, Sales and Marketing EMA, Pfizer, tofacitinib

The European Medicines Agency has accepted Pfizer’s arthritis drug tofacitinib for review.Tofacitinib is a novel, oral JAK inhibitor being studied …

News
Sweden pic

What does it take to make integrated care work?

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Feature

Andreas Pott appointed deputy executive director of European Medicines Agency

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Europe

The European Medicines Agency’s new executive director Guido Rasi has appointed Andreas Pott as deputy executive director. Pott’s appointment follows …

Appointment
Avastin picture

FDA pulls Roche’s Avastin for breast cancer

November 21, 2011
Research and Development, Sales and Marketing FDA, Roche, avastin

The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …

News
dipankar_bhattacharjee_teva

Dipankar Bhattacharjee becomes vice president of Teva Northern Europe

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Dipankar Bhattacharjee has been promoted to vice president of UK and Teva Northern Europe. Teva said that as part of …

Appointment

Manufacturing drives growth at Wuxi Pharmatech

November 21, 2011
Manufacturing and Production WuXi PharmaTech

Chinese outsourcing services specialist WuXi Pharmatech reported a 24% increase in third-quarter sales to $104 million thanks to a robust …

News

Novartis workers stage flash strike over job cuts

November 21, 2011
Manufacturing and Production Novartis, Switzerland, job cuts

Workers at Novartis’ Nyon facility in Switzerland carried out a strike to protest the closure of the plant, but called …

News

AstraZeneca’s thyroid cancer drug gets CHMP nod

November 21, 2011
Sales and Marketing AstraZeneca, CHMP, Caprelsa, vandetanib

AstraZeneca’s thyroid cancer pill Caprelsa has taken a step closer to European approval after being recommended by the CHMP.Caprelsa (vandetanib) …

News
rampd-charnwood

AstraZeneca’s UK research centre prepares to close

November 18, 2011
Research and Development AstraZeneca, Charnwood

AstraZeneca has thrown more light on the pending closure of its UK R&D site in Charnwood, saying that 90% of …

News

First stem cell trial halted due to costs

November 18, 2011
Research and Development Geron, Stem cells

One of the world’s first stem cell trials has been put on hold due to ‘uncertain economic conditions’.Geron, the firm undertaking …

News

Bayer forecasts €11 billion growth in Asia

November 17, 2011
Bayer, China, emerging markets

Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …

News

Industry supports bid to revitalise antibiotic research

November 17, 2011
Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic

The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …

News

Jeremy Poland

November 17, 2011
Sales and Marketing MSI Consultancy

Pharmaceutical consultancy firm The MSI Consultancy has appointed Jeremy Poland as a Graduate Analyst in its Marketing Sciences division. Jeremy …

Appointment

NICE will not back Eisai’s Halaven

November 17, 2011
Medical Communications, Sales and Marketing Eisai, Halaven, NICE, breast cancer

NICE has not recommended Eisai’s novel breast cancer drug Halaven due to concerns over its safety and cost.In draft guidance …

News
life_healthcare_jpg

Life Healthcare makes four new appointments

November 16, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life healthcare communications

Life Healthcare Communications has made four new appointments, adding to its client service, creative and digital teams. Vicki Marsh joins …

Appointment

GSK diabetes drug fails head-to-head against Victoza

November 16, 2011
Sales and Marketing GLP-1, Victoza, albiglutide, diabetes

GlaxoSmithKline’s long-acting diabetes drug albiglutide has failed in a head-to-head trial against Novo Nordisk’s Victoza. Albiglutide is an injectable glucagon-like …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026